Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer

  1. Caputo, S.M.
  2. Léone, M.
  3. Damiola, F.
  4. Ehlen, A.
  5. Carreira, A.
  6. Gaidrat, P.
  7. Martins, A.
  8. Brandão, R.D.
  9. Peixoto, A.
  10. Vega, A.
  11. Houdayer, C.
  12. Delnatte, C.
  13. Bronner, M.
  14. Muller, D.
  15. Castera, L.
  16. Guillaud-Bataille, M.
  17. Søkilde, I.
  18. Uhrhammer, N.
  19. Demontety, S.
  20. Tubeuf, H.
  21. Castelain, G.
  22. Jensen, U.B.
  23. Petitalot, A.
  24. Krieger, S.
  25. Lefol, C.
  26. Moncoutier, V.
  27. Boutry-Kryza, N.
  28. Nielsen, H.R.
  29. Silninilkova, O.
  30. Stoppa-Lyonnet, D.
  31. Spurdle, A.B.
  32. Teixeira, M.R.
  33. Coulet, F.
  34. Thomassen, M.
  35. Rouleau, E.
  36. Show all authors +
Journal:
Oncotarget

ISSN: 1949-2553

Year of publication: 2018

Volume: 9

Issue: 25

Pages: 17334-17348

Type: Article

DOI: 10.18632/ONCOTARGET.24671 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus